Richard Rodgers
Director/Board Member at ARDELYX, INC.
Net worth: 2 M $ as of 2024-04-29
Network origin in Richard Rodgers first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 34 | |
| Public Company | Pharmaceuticals: Major | 31 | |
| Extinct | Telecommunications Equipment | 30 | |
St. Cloud State University
30
| College/University | Other Consumer Services | 30 |
The Curtis L. Carlson School of Management
23
| College/University | Other Consumer Services | 23 |
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 20 | |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN.
16
| Extinct | Pharmaceuticals: Major | 16 |
| Extinct | Pharmaceuticals: Major | 13 | |
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
7
| Extinct | Pharmaceuticals: Major | 7 |
MedSource Technologies Holdings LLC
 MedSource Technologies Holdings LLC Medical SpecialtiesHealth Technology MedSource Technologies Holdings LLC provides engineering, manufacturing, and supply chain management services for the medical device industry. The company was founded by Andrew D. Lipman, Richard J. Effress, and William John Kidd on April 1998 and is headquartered in Wilmington, MA.
1
| Extinct | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Rodgers via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Sales & Marketing General Counsel Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Sales & Marketing | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact Sales & Marketing Corporate Officer/Principal | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Investment Managers | Director/Board Member Private Equity Investor Director/Board Member | |
| University of Maryland | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| MAXCYTE, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chairman | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| New York University | College/University | Undergraduate Degree Undergraduate Degree | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
Arcion Therapeutics LLC
 Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Operating Officer Chairman | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree Undergraduate Degree | |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| University of Wisconsin | College/University | Graduate Degree Undergraduate Degree | |
| Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
| The State University of New York | College/University | Undergraduate Degree Doctorate Degree | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman Sales & Marketing | |
| Stanford Law School | College/University | Graduate Degree Graduate Degree | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| AT&T INC. | Wireless Telecommunications | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Medical/Nursing Services | Corporate Officer/Principal Chief Executive Officer |
Statistics
International
| United States | 48 |
| United Kingdom | 3 |
| Canada | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 4 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 427 |
| Corporate Officer/Principal | 246 |
| Chairman | 115 |
| Independent Dir/Board Member | 110 |
| Chief Executive Officer | 91 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Soon-Shiong | 52 |
| Annalisa Jenkins | 51 |
| David Mott | 45 |
| Beth Seidenberg | 39 |
| Arnold Lewis Oronsky | 35 |
| Lonnie Moulder | 31 |
| James Manuso | 29 |
| William Cadogan | 26 |
| Mary Lynne Hedley | 25 |
| David Collier | 24 |
| Cam Gallagher | 24 |
| Mina Sooch | 23 |
| Gregg Alton | 22 |
| Peter G. Schultz | 21 |
| Mike Raab Raab | 20 |
- Stock Market
- Insiders
- Richard Rodgers
- Company connections
